InsiderTrades.com logo
The Next Step of Their Control Is Here …
From Weiss Ratings   |   Ad
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
4 simple steps to protect your privacy and money before it’s too late.

EQ Insider Trading

Insider Ownership Percentage: 30.30%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Equillium Insider Trading History Chart

This chart shows the insider buying and selling history at Equillium by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Equillium Share Price & Price History

Current Price: $1.71
Price Change: ▼ Price Decrease of -0.1 (-5.52%)
As of 04/26/2024 01:00 AM ET

This chart shows the closing price history over time for EQ up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Next Step of Their Control Is Here …
From Weiss Ratings   |   Ad
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
4 simple steps to protect your privacy and money before it’s too late.

Equillium Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/29/2022Jason A KeyesCFOSell7,000$2.83$19,810.0077,720View SEC Filing Icon  
6/6/2022Jason A KeyesCFOSell5,000$2.52$12,600.0084,720View SEC Filing Icon  
4/4/2022Jason A KeyesCFOSell8,000$3.18$25,440.0023,296View SEC Filing Icon  
12/1/2021Jason A KeyesCFOSell5,000$5.08$25,400.00View SEC Filing Icon  
10/6/2021Stephen ConnellyInsiderSell8,092$7.01$56,724.92View SEC Filing Icon  
9/27/2021Jason A KeyesCFOSell8,000$6.74$53,920.00View SEC Filing Icon  
7/27/2021Jason A. KeyesCFOSell5,000$5.72$28,600.0017,711View SEC Filing Icon  
6/8/2021Stephen ConnellyInsiderSell10,495$7.18$75,354.10999,509View SEC Filing Icon  
6/4/2021Stephen ConnellyInsiderSell13,539$7.01$94,908.39999,509View SEC Filing Icon  
5/26/2021Jason A KeyesCFOSell5,000$6.50$32,500.00View SEC Filing Icon  
See Full Table
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

SEC Filings (Institutional Ownership Changes) for Equillium (NASDAQ:EQ)

27.05% of Equillium stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at EQ by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Equillium Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2024Decheng Capital LLC4,447,308$3.22M0.9%N/A12.663%Search for SEC Filing on Google Icon
8/9/2023DCF Advisers LLC111,623$84K0.0%-28.9%0.324%Search for SEC Filing on Google Icon
5/2/2023Victory Capital Management Inc.345,861$0.25M0.0%-89.2%1.005%Search for SEC Filing on Google Icon
2/14/2023True North Advisors LLC265,370$0.27M0.1%+50.5%0.771%Search for SEC Filing on Google Icon
2/13/2023Callan Capital LLC103,688$0.11M0.0%N/A0.301%Search for SEC Filing on Google Icon
2/9/2023Victory Capital Management Inc.3,198,745$3.52M0.0%-12.4%9.296%Search for SEC Filing on Google Icon
1/24/2023Capital CS Group LLC24,000$25K0.0%N/A0.070%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC24,141$54K0.0%N/A0.070%Search for SEC Filing on Google Icon
11/2/2022Victory Capital Management Inc.3,651,084$8.11M0.0%+2.1%10.651%Search for SEC Filing on Google Icon
8/11/2022DCF Advisers LLC114,027$0.23M0.1%-31.2%0.333%Search for SEC Filing on Google Icon
8/1/2022Victory Capital Management Inc.3,577,211$7.30M0.0%-0.6%10.436%Search for SEC Filing on Google Icon
5/16/2022Cota Capital Management LLC562,278$1.77M0.4%N/A1.640%Search for SEC Filing on Google Icon
5/10/2022Decheng Capital Management III Cayman LLC4,447,308$14.01M4.3%N/A12.975%Search for SEC Filing on Google Icon
5/4/2022Victory Capital Management Inc.3,597,799$11.33M0.0%+8.2%10.495%Search for SEC Filing on Google Icon
2/15/2022Samsara BioCapital LLC615,541$2.32M0.5%-16.6%2.094%Search for SEC Filing on Google Icon
2/7/2022Victory Capital Management Inc.3,325,050$12.47M0.0%+4.9%11.313%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Securities LLC83,948$0.57M0.0%N/A0.286%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC154,185$1.05M0.0%+2.4%0.525%Search for SEC Filing on Google Icon
11/2/2021Victory Capital Management Inc.3,170,199$21.62M0.0%+9.4%10.789%Search for SEC Filing on Google Icon
8/17/2021Samsara BioCapital LLC738,176$4.35M0.5%-3.4%2.512%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC141,200$0.83M0.0%+38.4%0.481%Search for SEC Filing on Google Icon
8/16/2021State Street Corp30,756$0.18M0.0%N/A0.105%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.218,162$1.29M0.0%N/A0.742%Search for SEC Filing on Google Icon
8/13/2021DCF Advisers LLC77,538$0.46M0.2%N/A0.267%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC150,582$0.89M0.0%+16.7%0.519%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.840,545$4.95M0.0%+31.4%2.894%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG356,461$2.10M0.0%+1.8%1.227%Search for SEC Filing on Google Icon
8/3/2021Victory Capital Management Inc.2,896,875$17.06M0.0%+1.0%9.975%Search for SEC Filing on Google Icon
5/21/2021Citadel Advisors LLC21,366$0.15M0.0%N/A0.074%Search for SEC Filing on Google Icon
5/18/2021Millennium Management LLC63,012$0.45M0.0%+413.3%0.217%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC21,366$0.15M0.0%N/A0.074%Search for SEC Filing on Google Icon
5/18/2021Samsara BioCapital LLC764,403$5.47M1.0%-28.8%2.632%Search for SEC Filing on Google Icon
5/17/2021Sphera Funds Management LTD.254,184$1.82M0.1%N/A0.875%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp34,055$0.24M0.0%+42.9%0.117%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC129,072$0.92M0.0%+99.0%0.444%Search for SEC Filing on Google Icon
5/7/2021BlackRock Inc.32,423$0.23M0.0%-53.1%0.112%Search for SEC Filing on Google Icon
5/4/2021Victory Capital Management Inc.2,868,858$20.51M0.0%+28.1%9.879%Search for SEC Filing on Google Icon
4/29/2021Vigilare Wealth Management18,000$0.13M0.1%-32.3%0.062%Search for SEC Filing on Google Icon
2/25/2021Hsbc Holdings PLC16,944$94K0.0%N/A0.068%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC18,247$98K0.0%N/A0.074%Search for SEC Filing on Google Icon
2/17/2021Jane Street Group LLC21,230$0.11M0.0%N/A0.086%Search for SEC Filing on Google Icon
2/16/2021Squarepoint Ops LLC20,235$0.11M0.0%N/A0.082%Search for SEC Filing on Google Icon
2/11/2021Northern Trust Corp23,827$0.13M0.0%+82.2%0.096%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC41,509$0.22M0.0%-61.3%0.168%Search for SEC Filing on Google Icon
2/9/2021Bank of New York Mellon Corp15,261$82K0.0%N/A0.062%Search for SEC Filing on Google Icon
2/5/2021BlackRock Inc.69,153$0.37M0.0%+221.1%0.280%Search for SEC Filing on Google Icon
2/1/2021Victory Capital Management Inc.2,239,735$11.98M0.0%-4.9%9.057%Search for SEC Filing on Google Icon
1/14/2021Vigilare Wealth Management26,600$0.14M0.1%N/A0.108%Search for SEC Filing on Google Icon
11/16/2020Samsara BioCapital LLC1,074,285$6.20M1.7%N/A4.344%Search for SEC Filing on Google Icon
11/13/2020Morgan Stanley9,573$55K0.0%N/A0.039%Search for SEC Filing on Google Icon
11/13/2020Cetera Advisor Networks LLC57,425$0.33M0.0%N/A0.298%Search for SEC Filing on Google Icon
11/9/2020Victory Capital Management Inc.2,354,309$13.59M0.0%+36.2%12.222%Search for SEC Filing on Google Icon
11/9/2020Kestra Private Wealth Services LLC60,850$0.35M0.0%N/A0.316%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.21,535$0.13M0.0%+14.2%0.112%Search for SEC Filing on Google Icon
11/5/2020California Public Employees Retirement System12,100$70K0.0%N/A0.063%Search for SEC Filing on Google Icon
11/5/2020First Trust Advisors LP32,518$0.19M0.0%N/A0.169%Search for SEC Filing on Google Icon
8/31/2020Bridgeway Capital Management Inc.75,000$0.22M0.0%N/A0.389%Search for SEC Filing on Google Icon
8/24/2020FMR LLC451,897$1.33M0.0%-27.1%2.346%Search for SEC Filing on Google Icon
8/17/2020Jacobs Levy Equity Management Inc.54,700$0.16M0.0%N/A0.284%Search for SEC Filing on Google Icon
8/14/2020Stifel Financial Corp42,619$0.13M0.0%+11.9%0.241%Search for SEC Filing on Google Icon
8/14/2020Alyeska Investment Group L.P.250,907$0.74M0.0%-12.3%1.419%Search for SEC Filing on Google Icon
8/13/2020FMR LLC451,897$1.33M0.0%-27.1%2.555%Search for SEC Filing on Google Icon
8/12/2020Goldman Sachs Group Inc.471,146$1.39M0.0%-11.6%2.664%Search for SEC Filing on Google Icon
5/15/2020Alyeska Investment Group L.P.286,180$0.78M0.0%-2.1%1.624%Search for SEC Filing on Google Icon
5/12/2020Victory Capital Management Inc.2,198,038$5.96M0.0%-1.6%12.475%Search for SEC Filing on Google Icon
5/4/2020Victory Capital Management Inc.2,198,038$5.96M0.0%-1.6%12.475%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Equillium logo
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a first-in-class monoclonal antibody that targets the immune checkpoint receptor CD6, which is in Phase III clinical trials for the treatment of acute graft-versus-host disease; completed Phase I clinical trial for the treatment of ulcerative colitis; and Phase I clinical trial for the treatment of lupus nephritis. It also develops EQ101 completed phase 1/2 for treatment of cutaneous T cell lymphoma and alopecia areata; and EQ302 to treat gastrointestinal indications. In addition, it serves dermatology, gastroenterology, rheumatology, hematology, transplant science, oncology, and pulmonology area. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Read More on Equillium

Today's Range

Now: $1.71
Low: $1.69
High: $1.85

50 Day Range

MA: $2.28
Low: $1.61
High: $3.00

52 Week Range

Now: $1.71
Low: $0.45
High: $3.25

Volume

80,229 shs

Average Volume

312,197 shs

Market Capitalization

$60.29 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.62

Who are the company insiders with the largest holdings of Equillium?

Equillium's top insider shareholders include:
  1. Jason A Keyes (CFO)
Learn More about top insider investors at Equillium.
The Next Step of Their Control Is Here …
From Weiss Ratings   |   Ad
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
4 simple steps to protect your privacy and money before it’s too late.